Filtered By:
Source: American Journal of Neuroradiology
Drug: Iohexol

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Navigating Supply Chain Disruptions of Iodinated Contrast Agent for Neuroimaging and How Business Intelligence Can Help the Decision Process ADULT BRAIN
SUMMARY: A recent coronavirus disease 2019–related shutdown of the main production facility of iohexol in China has led to massive shortages of iodinated contrast material across the globe. This shortage has also jeopardized neuroimaging. In this article, we describe remedies to reduce iodinated contrast material use for stroke imaging, which is its primary use in neuroimaging, that we have implemented in our hospital network.
Source: American Journal of Neuroradiology - July 7, 2022 Category: Radiology Authors: Bammer, R., Amukotuwa, S. A. Tags: ADULT BRAIN Source Type: research

Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial INTERVENTIONAL
CONCLUSIONS: While data favoring the use of iso-osmolal iodixanol for reperfusion of M1 occlusion following IV rtPA are inconclusive, potential pathophysiologic mechanisms suggesting clinical benefit warrant further investigation.
Source: American Journal of Neuroradiology - November 13, 2015 Category: Radiology Authors: Tomsick, T. A., Foster, L. D., Liebeskind, D. S., Hill, M. D., Carrozella, J., Goyal, M., von Kummer, R., Demchuk, A. M., Dzialowski, I., Puetz, V., Jovin, T., Morales, H., Palesch, Y. Y., Broderick, J., Khatri, P., Yeatts, S. D., for the IMS III Investig Tags: INTERVENTIONAL Source Type: research